Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months
GFG-US-REC
A Prospective, Randomized, Controlled, Double-blind, Multi-center Study to Assess Non-inferiority of Geistlich Fibro-Gide® in Comparison to Connective Tissue Graft for the Treatment of Recession Defects
1 other identifier
interventional
30
1 country
3
Brief Summary
This double blind, randomized, split mouth study evaluates the non-inferiority of Geistlich Fibro-Gide® in comparison to connective tissue graft for the treatment of Miller Class I or II recession defects at 6 months post treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2018
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
September 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 22, 2020
CompletedAugust 10, 2021
March 1, 2020
1.3 years
September 18, 2019
August 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in percent root coverage
Change in percent root coverage compared to baseline
6 months post-treatment
Secondary Outcomes (10)
Safety Endpoints: number and frequency of (S)AEs over all and by organ class
1, 2, 4, 7, 12 and 24 weeks and year 1,3 and 5 post treatment
General Periodontal Examination (GPE)
baseline (day 0) and 6 months; 1, 3, 5 years post-treatment
Assessment of Wound Healing
1, 2, 4, 12 weeks post-treatment
Assessment of Wound Healing
1, 2, 4, 12 weeks post-treatment
Assessment of Wound Healing
1, 2, 4, 12 weeks post-treatment
- +5 more secondary outcomes
Study Arms (2)
Control: CAF + CTG
ACTIVE COMPARATORFollowing root preparation and conditioning, the CTG is obtained from the palate according to the randomization scheme and shaped to the recipient site and may be sutured to the papilla region and the coronally advanced flap (CAF) is sutured into place.
Test: CAF + Geistlich Fibro-Gide® (test)
EXPERIMENTALFollowing root preparation and conditioning, Geistlich Fibro-Gide® is cut to size and shaped to the recipient and may be sutured and the coronally advanced flap (CAF) is sutured into place.
Interventions
Surgical recession root coverage with coronally advanced flap in combination with Geistlich Fibro-Gide
Surgical recession root coverage with coronally advanced flap in combination with CTG
Eligibility Criteria
You may qualify if:
- to 75 years of age, inclusive.
- Subjects must have at least two teeth with buccal Miller Class I or II recession type defects, 3 mm deep and 3 mm wide on the same tooth in the contralateral quadrant of the same jaw
- Defects should be similar in size and morphology
- Teeth with root canals should be asymptomatic, completed at least 6 months prior
- At least 1mm KT
- Subjects with parafunctional habits must wear a bite guard to be included.
You may not qualify if:
- Participation within the previous 30 days in other investigational clinical trials.
- Class V restorations or abfractions that obliterate the CEJ.
- Subjects whose teeth have extremely prominent root surfaces -greater than 2mm facially to the adjacent teeth measured at the level of the CEJ.
- Systemic conditions that could influence wound healing or any other conditions that would preclude periodontal surgery.
- Taking medications that compromise wound healing.
- Acute infectious lesions in the areas intended for surgery.
- Untreated moderate to severe periodontal disease.
- Weekly or more frequent use of nicotine products within the past 6 months.
- Females who are pregnant or lactating, or sexually active female subjects who are of childbearing potential and who are not using hormonal or barrier methods of birth control.
- Subjects who require sedation in order to undergo surgery.
- Molars, teeth with axial mobility or interproximal loss of attachment, or full coverage crowns or veneers do not qualify.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Geistlich Pharma AGlead
- Medelis Inc.collaborator
Study Sites (3)
Seven Lakes Periodontitis
Fenton, Michigan, 99999, United States
Perio Health Professionals
Houston, Texas, 77063, United States
Oral Health Specialists
Tacoma, Washington, 99999, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael K McGuire, DDS MSD
PerioHealth Professionals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Double-blind (Outcomes Examiner, Subject)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2019
First Posted
February 7, 2020
Study Start
September 1, 2018
Primary Completion
January 4, 2020
Study Completion
July 22, 2020
Last Updated
August 10, 2021
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share